Acknowledgements This work was supported by click here grants from the Natural MM-102 clinical trial Science Foundation of China, No. 81060201 and No. 81060277; the Higher School Specialized Research Foundation for the Doctoral Program of China, No. 20114503110002; the Postdoctoral Science Foundation of China, No.
201003342; and the Natural Science Foundation of Guangxi, No. 2011GXNSFA018273. References 1. Sun P, Xiang JB, Chen ZY: Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer. Br J Surg 2009, 96:26–33.PubMedCrossRef 2. Hirasawa T, Gotoda T, Miyata S, Kato Y, Shimoda T: Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer. Gastric Cancer 2009, 12:148–52.PubMedCrossRef 3. Park do Y, Srivastava A, Kim GH, Mino-Kenudson M, Deshpande V: CDX2 expression in the intestinal-type gastric epithelial neoplasia: frequency and significance. Mod Pathol 2010, 23:54–61.PubMedCrossRef
4. Xie Y, Li L, Wang X, Qin Y, Qian Q: Overexpression of Cdx2 inhibits progression of gastric cancer in vitro. Int J Oncol 2010, 36:509–16.PubMed 5. Kim HS, Lee JS, Freund JN, Min KW, Lee JS: CDX-2 homeobox gene expression in human gastric {Selleck Anti-cancer Compound Library|Selleck Anticancer Compound Library|Selleck Anti-cancer Compound Library|Selleck Anticancer Compound Library|Selleckchem Anti-cancer Compound Library|Selleckchem Anticancer Compound Library|Selleckchem Anti-cancer Compound Library|Selleckchem Anticancer Compound Library|Anti-cancer Compound Library|Anticancer Compound Library|Anti-cancer Compound Library|Anticancer Compound Library|Anti-cancer Compound Library|Anticancer Compound Library|Anti-cancer Compound Library|Anticancer Compound Library|Anti-cancer Compound Library|Anticancer Compound Library|Anti-cancer Compound Library|Anticancer Compound Library|Anti-cancer Compound Library|Anticancer Compound Library|Anti-cancer Compound Library|Anticancer Compound Library|Anti-cancer Compound Library|Anticancer Compound Library|buy Anti-cancer Compound Library|Anti-cancer Compound Library ic50|Anti-cancer Compound Library price|Anti-cancer Compound Library cost|Anti-cancer Compound Library solubility dmso|Anti-cancer Compound Library purchase|Anti-cancer Compound Library manufacturer|Anti-cancer Compound Library research buy|Anti-cancer Compound Library order|Anti-cancer Compound Library mouse|Anti-cancer Compound Library chemical structure|Anti-cancer Compound Library mw|Anti-cancer Compound Library molecular weight|Anti-cancer Compound Library datasheet|Anti-cancer Compound Library supplier|Anti-cancer Compound Library in vitro|Anti-cancer Compound Library cell line|Anti-cancer Compound Library concentration|Anti-cancer Compound Library nmr|Anti-cancer Compound Library in vivo|Anti-cancer Compound Library clinical trial|Anti-cancer Compound Library cell assay|Anti-cancer Compound Library screening|Anti-cancer Compound Library high throughput|buy Anticancer Compound Library|Anticancer Compound Library ic50|Anticancer Compound Library price|Anticancer Compound Library cost|Anticancer Compound Library solubility dmso|Anticancer Compound Library purchase|Anticancer Compound Library manufacturer|Anticancer Compound Library research buy|Anticancer Compound Library order|Anticancer Compound Library chemical structure|Anticancer Compound Library datasheet|Anticancer Compound Library supplier|Anticancer Compound Library in vitro|Anticancer Compound Library cell line|Anticancer Compound Library concentration|Anticancer Compound Library clinical trial|Anticancer Compound Library cell assay|Anticancer Compound Library screening|Anticancer Compound Library high throughput|Anti-cancer Compound high throughput screening| carcinoma and precursor lesions. J Gastroenterol Hepatol 2006, 21:438–42.PubMedCrossRef 6. Song JH, Kim CJ, Cho YG, Chae JS, Cao Z: Genetic alterations of the Cdx2 gene in gastric cancer. APMIS 2008, 116:74–80.PubMedCrossRef 7. Kang JM, Lee BH, Kim N, Lee HS, Lee HE: CDX1 and CDX2 expression in intestinal metaplasia, dysplasia and gastric cancer. J Korean Med Sci 2011, 26:647–53.PubMedCrossRef 8. Liu Q, Teh M, Ito K, Shah N, Ito Y: CDX2 expression
is progressively decreased in human gastric intestinal metaplasia, Racecadotril dysplasia and cancer. Mod Pathol 2007, 20:1286–97.PubMedCrossRef 9. Ge J, Chen Z, Wu S, Yuan W, Hu B: A clinicopathological study on the expression of cadherin-17 and caudal-related homeobox transcription factor (CDX2) in human gastric carcinoma. Clin Oncol (R Coll Radiol) 2008, 20:275–83.CrossRef 10. Ru Y, Zhang L, Chen Q, Gao SG, Wang GP: Detection and clinical significance of lymph node micrometastasis in gastric cardia adenocarcinoma. J Int Med Res 2012, 40:293–9.PubMed 11. Qin R, Wang NN, Chu J, Wang X: Expression and significance of homeodomain protein Cdx2 in gastric carcinoma and precancerous lesions. World J Gastroenterol 2012, 18:3296–302.PubMed 12. Xiao ZY, Ru Y, Sun JT, Gao SG, Wang YF: Expression of CDX2 and villin in gastric cardiac intestinal metaplasia and the relation with gastric cardiac carcinogenesis. Asian Pac J Cancer Prev 2012, 13:247–50.PubMedCrossRef 13. Okayama H, Kumamoto K, Saitou K, Hayase S, Kofunato Y: CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer.